Category: Life Sciences
Life Sciences market research reports by Roots Analysis
-
CAR-T Cell Therapies: Intellectual Property Landscape
CAR-T Cell Therapies: Intellectual Property Landscape Cancer, one of the leading causes of death worldwide, claimed close to 10 million lives annually Although there are several treatment options available to control disease progression and keep malignant cells from spreading throughout the body, l ... Read More
-
Vaccine Adjuvant Market (2nd Edition), 2022-2035
Vaccine Adjuvant Market (2nd Edition), 2022-2035 As per recent estimates (reported in May 2022), more than 11.6 billion doses of COVID-19 vaccines have been administered across 184 countries; this value roughly translates to 20.9 million doses per day. Vaccines have enabled the prevention of more t ... Read More
-
Viral Vaccine Cell Culture Media Market, 2022-2035
Viral Vaccine Cell Culture Media Market, 2022-2035 Over the past few years, a number of advanced vaccines targeting a myriad of disease indications have received approval from various regulatory authorities. Post the onset of COVID-19, there has been a surge in the demand for viral vaccines. In fac ... Read More
-
Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035
Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035 Since the approval of Orthoclone OKT3, a murine monoclonal antibody against T cell expressed CD3 (for the treatment of acute transplant rejection) in 1986, antibody based pharmacological interventions have evolved into a promi ... Read More
-
Flow Cytometry Services Market, 2022-2035
Flow Cytometry Services Market, 2022-2035 First introduced in 1950s, the flow cytometry technique has gained significant attention in the past few decades. This can be attributed to the fact that flow cytometry has been demonstrated to be capable of overcoming various challenges associated with conv ... Read More
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis ... Read More
-
Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)
Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for No ... Read More
-
Artificial Intelligence in Healthcare: Intellectual Property Landscape
Artificial Intelligence in Healthcare: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) The globa ... Read More
-
Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific)
Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific) 1. It is a well-known fact that c ... Read More
-
Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Activity, [E] Startup Health Indexing and Company Valuation Analysis, [F] Financial Analysis of Key Public Ventures, [G] Market Forecast and Opportunity Analysis, [H] Insights from Publicly Disclosed Investor Exits and [I] Key Acquisition Targets)
Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Activity, [E] Startup Health Indexing and Company ... Read More
Research Assistance
